The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence Source: Sleep and Breathing Conference 2021 Year: 2021
The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Obstructive sleep apnoea and incident diabetes mellitus in a Chinese population Source: International Congress 2017 – Lung function, respiratory symptoms and obstructive sleep apnoea Year: 2017
Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Prevalence of stroke in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2007; 30: Suppl. 51, 331s Year: 2007
Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019
Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Oxygen desaturation is associated with diabetes mellitus in patients with obstructive sleep apnoea Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012
Prevalence of sleep apnea in patients with resistant hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Prevalence of nocturia in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 646s Year: 2006
Prevalence of non cardiovascular disorders in patients with obstructive sleep apnoea and in ”healthy“ snorers Source: Eur Respir J 2003; 22: Suppl. 45, 92s Year: 2003
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Prevalence of obstructive sleep apnea among patients with resistant arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 115s Year: 2005
The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002
High prevalence of obstructive sleep apnea syndrome in a type 1 diabetic adult population: A pilot study Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 322s Year: 2002
Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain Year: 2011